Clinical Trial Update: A Study of Pitolisant in Participants With Prader-Willi Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pitolisant for Prader-Willi syndrome is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Pitolisant (pitolisant)

Snippet

Sponsor: Harmony Biosciences Management, Inc. | Conditions: Prader-Willi Syndrome | Phase 3 | Status: ENROLLING_BY_INVITATION